RO-54023 |
KLONOPIN RAPIDLY DISINTEGRATING |
NSC-179913 |
KLONOPIN |
RIVOTRIL |
RO-5-4023 |
CLONAZEPAM |
CLONAZEPAM CIV |
1,3-DIHYDRO-7-NITRO-5-(2-CHLOROPHENYL)-2H-1,4.BENZODIAZEPIN-2-ONE |
5-(2-CHLOROPHENYL)-7-NITRO-1H-BENZO[E][1,4]DIAZEPIN-2(3H)-ONE |
CLONAZEPAMUM |
5-(O-CHLOROPHENYL)-7-NITRO-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE |
RO-5423 |
5-(2-CHLORO-PHENYL)-7-NITRO-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE |
KLONOPIN® |
chembl:CHEMBL452 |
pubchem.compound:2802 |
drugbank:01068 |
rxcui:2598 |
chemidplus:1622-61-3 |
Year of Approval | 1975 |
Drug Class | anticonvulsants |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | anticonvulsant |
Drug Categories | benzodiazepines and benzodiazepine derivatives |
Drug Categories | cytochrome p-450 cyp2e1 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | muscle relaxants |
Drug Categories | muscle relaxants, centrally acting agents |
ligand |
positive modulator (activating) |
allosteric modulator |
Trial Name | JZP-8 |
Novel drug target | Established target |
Details of the Assay for Interaction | Assay using recombinant GABA<sub>A</sub> channels with subunit composition; α1β1γ2. |
n/a |
Trial Name | JZP-8 |
Novel drug target | Established target |
n/a |
Trial Name | JZP-8 |
Novel drug target | Established target |
n/a |
Trial Name | JZP-8 |
Novel drug target | Established target |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | JZP-8 |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | JZP-8 |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | JZP-8 |
positive modulator (activating) |
Trial Name | JZP-8 |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
allosteric modulator |
Trial Name | JZP-8 |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | JZP-8 |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
allosteric modulator |
Details of the Assay for Interaction | Assay using recombinant GABA<sub>A</sub> channels with subunit composition; α3β1γ2. |
Specific Action of the Ligand | Positive |
Endogenous Drug? | False |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | JZP-8 |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | JZP-8 |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Novel drug target | Established target |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | JZP-8 |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | JZP-8 |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | JZP-8 |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
CLONAZEPAM | DrugBank Drug Name |
1622-61-3 | CAS Number |
Accel-clonazepam | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | illicit |
CLONAZEPAM | Primary Drug Name |
Drug Class | anticonvulsants |
Year of Approval | 1975 |
Drug Indications | anticonvulsant |
Drug Class | Small Molecule |
FDA Approval | approved |
C28935 | NCI drug code |
CLONAZEPAM | GuideToPharmacology Ligand Name |
D0CP4E | TTD Drug ID |